1OVZ,1M4K,1OLL,1P6F,2D3V,2GI7


Conserved Protein Domain Family
IgC2_D2_LILR_KIR_like

?
cd05711: IgC2_D2_LILR_KIR_like 
Second immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors, Natural killer inhibitory receptors (KIRs) and similar domains; member of Immunoglobulin Constant-2 set of IgSF domains
The members here are composed of the second immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILRs), Natural killer inhibitory receptors (KIRs, also known as also known as cluster of differentiation (CD) 158), and similar proteins. This group includes LILRB1 (also known as LIR-1), LILRA5 (also known as LIR9), an activating natural cytotoxicity receptor NKp46, the immune-type receptor glycoprotein VI (GPVI), and the IgA-specific receptor Fc-alphaRI (also known as cluster of differentiation (CD) 89). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3, and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1, LILRB2 (also known as LIR-2), and LILRB3 (also known as LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs), it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LILRB1, and LILRB2, show detectable binding to class I MHC molecules; ligands for the other members have yet to be determined. The extracellular portions of the different LIR proteins contain different numbers of Ig-like domains for example, four in the case of LILRB1, and LILRB2, and two in the case of LILRB4 (also known as LIR-5). The activating natural cytotoxicity receptor NKp46 is expressed in natural killer cells, and is organized as an extracellular portion having two Ig-like extracellular domains, a transmembrane domain, and a small cytoplasmic portion. GPVI, which also contains two Ig-like domains, participates in the processes of collagen-mediated platelet activation and arterial thrombus formation. Fc-alphaRI is expressed on monocytes, eosinophils, neutrophils, and macrophages; it mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Killer cell immunoglobulin-like receptors (KIRs; also known as CD158 for human KIR) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. KIRs are a family of highly polymorphic activating and inhibitory receptors that serve as key regulators of human NK cell function. The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The major ligands for KIR are MHC class I (HLA-A, -B or -C) molecules.
Statistics
?
PSSM-Id: 409376
Aligned: 10 rows
Threshold Bit Score: 134.062
Created: 12-Sep-2007
Updated: 25-Oct-2021
Structure
?
Program:
Drawing:
Aligned Rows:
  next features
Conserved site includes 5 residues -Click on image for an interactive view with Cn3D
Feature 1:Ig strand A [structural motif]
Evidence:
  • None

Sequence Alignment
?
Format: Row Display: Color Bits: Type Selection:
Feature 1      #####                                                                          
1OVZ_A    104 KPFLSADRGLVLMPGENISLTCSsahipfDRFSLAKegel-----slpqHQSGe-------hPANFSLGPvdlnVSGIYR 171 human
1M4K_A      7 KPSLLAHPGPLVKSEETVILQCWsdv-rfEHFLLHRegky------kdtLHLIgehh-dgvsKANFSIGPmmqdLAGTYR 78  human
1OLL_A     99 TPTLSVHPGPEVISGEKVTFYCRldt-atSMFLLLKegrs------shvQRGYgk------vQAEFPLGPvttaHRGTYR 165 Homo sapiens
1P6F_A    102 TPTLSVHPGPEVISGEKVTFYCRldt-atSMFLLLKegrs------shvQRGYgk------vQAEFPLGPvttaHRGTYR 168 human
2D3V_A    100 KPTLSALPSPVVTSGENVTLQCGsrl-rfDRFILTEegdh------klsWTLDsqltpsgqfQALFPVGPvtpsHRWXLR 172 human
2GI7_A     94 KPSLSAQPGPAVSSGGDVTLQCQtry-gfDQFALYKegdpapyknperwYRAS---------FPIITVTAa---HSGTYR 160 human
P43630     28 KPFLSARPSTVVPRGGHVALQCHyrr-gfNNFMLYKedrs-----hvpiFHGRi-------fQESFIMGPvtpaHAGTYR 94  human
P83556     28 KPFLCASPSYIVPQGQNVTLICDshs-kpNIFKVYKedgf-----pilqLHEKt-------fTKSLDIGPvtpeYAGTYR 94  Norway rat
P83556    121 KPFLIAPQTPLANSGENVTLECHsei-mfDTYILTShrmeil-ketlqhFQEShfs----gsYASFTIGPmtpdHSGTYT 194 Norway rat
BAD12825  123 KPSLLAQPSPLVQSGQNVTLKCCsei-vfDSFILHRegvmesplhlvgqFHDGg-------sQATFFLGPvtiaHAGTYR 194 horse
Feature 1                            
1OVZ_A    172 CYGWynrspylWSFPSNALELVV 194 human
1M4K_A     79 CYGSvthspyqLSAPSDPLDIVI 101 human
1OLL_A    166 CFGSynn--haWSFPSEPVKLLV 186 Homo sapiens
1P6F_A    169 CFGSynn--haWSFPSEPVKLLV 189 human
2D3V_A    173 CYGSrrhilqvWSEPSDLLEIPV 195 human
2GI7_A    161 CYSFssrdpylWSAPSDPLELVV 183 human
P43630     95 CRGSrphsltgWSAPSNPLVIMV 117 human
P83556     95 CFHHqyp--neISAHSEPLKIII 115 Norway rat
P83556    195 CYGAynhslyeWSDSSDPVDIKI 217 Norway rat
BAD12825  195 CFGSinyssyeWSTPSDPLNIKI 217 horse

| Disclaimer | Privacy statement | Accessibility |
NCBI Home NCBI Search NCBI SiteMap